KALV EBITDA Margin
Kalvista Pharmaceuticals Inc · EBITDA Margin
KALV EBITDA Margin
Latest reported-101.19%period ending
KALV TTM EBITDA Margin (-2203.10% → -101.19%)
TTM ebitda margin
High-resolution chart · PNG
KALV ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -101.1911% | |
| -292.8261% | |
| -1,240.7197% | |
| -13,132.8191% | |
| -1,263.363% | |
| -893.0754% | |
| -478.6396% | |
| -312.0883% | |
| -355.4528% | |
| -255.4201% | |
| -201.4958% | |
| -182.5871% | |
| -117.6497% | |
| -115.0598% | |
| -166.969% | |
| -220.6934% | |
| -563.8495% | |
| -1,545.2997% | |
| -4,061.788% | |
| -3,570.1867% | |
| -5,582.8202% | |
| -54,799.95% | |
| -58,351.7241% | |
| -77,800% | |
| -72,189.6552% | |
| -67,358.6207% | |
| -57,153.125% | |
| -50,663.3333% | |
| -42,148.2759% | |
| -2,203.1026% |